- Jul 21, 2013
- 842
- Tinnitus Since
- 01/2013
- Cause of Tinnitus
- Acoustic trauma from headphones
She wanted to make sure that enough stimulation was coming through the auditory system. I would be surprised if that threshold wasn't raised for the commercial version.Does anyone know why Dr. Shore excluded people with greater hearing loss than -50 dB from the study?
That's something I never even thought about. I'm concerned as labyrinthitis left me with severe hearing loss in my right ear (75-95 dB from 4000 to 8000 Hz), but normal left ear (0-20 dB).Remember they first tested this on animals, who I believe couldn't tell their their exact tinnitus frequency.
I'm just speculating here to be honest, but so far it is logical to assume so. Also, somewhere above it was being said that Dr. Shore herself said that plastic changes from one ear can happen to both DCN sides in the brain, meaning that treating one ear can possibly affect both sides. It's all assumptions at this point, but the results were very much promising.That's something I never even thought about. I'm concerned as labyrinthitis left me with severe hearing loss in my right ear (75-95 dB from 4000 to 8000 Hz), but normal left ear (0-20 dB).
Remember Dr. Shore told @dj_newark you could use the other ear:That's something I never even thought about. I'm concerned as labyrinthitis left me with severe hearing loss in my right ear (75-95 dB from 4000 to 8000 Hz), but normal left ear (0-20 dB).
Dr. Shore said:Tim,
I apologize for the tardy response, but I have been busy with deadlines.
The unilateral treatment is based on the animal studies with unilateral hearing loss, which can affect both cochlear nuclei. But, since tinnitus is generated in the brain, unilateral treatment appears to alleviate the perception of tinnitus on both sides. There are numerous pathways for influencing the other side.
Best wishes,
Susan
US in 2024, $4,990Who wants to guess:
Closest answer gets bragging rights.
- How much will Dr. Shore's device cost
- What year will it be released in
US $3,500Who wants to guess:
Closest answer gets bragging rights.
- How much will Dr. Shore's device cost
- What year will it be released in
No, it only works for somatic tinnitus right now. She says they'll investigate treating other forms of the disorder after the device is released. They'll also continue to refine the device after release so that it works better, faster and for more people.When my tinnitus is loud, I'm able to regulate it with all my face and neck muscles. I wonder if this device works for not just somatic tinnitus like what I have, but other types too, assuming the others are persisted in the DCN.
I'm guessing release in US in early 2024 at around the same price point of Lenire, ~$2200.Who wants to guess:
Closest answer gets bragging rights.
- How much will Dr. Shore's device cost
- What year will it be released in
That's nonsense. I've tested Lenire and I'm an absolute anti-Neuromod nerd. The acoustician looked at my audiogram and apparently made some adjustments to the software. Otherwise there are the same senseless sounds like piano, the sound of the sea, other instruments, etc. Complete nonsense, nothing is adjusted to the tinnitus frequency. Determining the tinnitus frequency is a difficult field anyway. So let's not continue the topic here, this is about Dr. Shore.Lenire's approach is similar to how hearing aids are customized for an individual's audiogram - they boost the signal where you have a dip to produce a profile that allows you to hear all frequencies at the correct volume. As previously mentioned, their system allows up to 80 dB loss.
Understood re Lenire - I wasn't talking about adjusting to the tinnitus frequency, only amplitude - they do boost the signal at those frequencies where there's hearing loss.That's nonsense. I've tested Lenire and I'm an absolute anti-Neuromod nerd. The acoustician looked at my audiogram and apparently made some adjustments to the software. Otherwise there are the same senseless sounds like piano, the sound of the sea, other instruments, etc. Complete nonsense, nothing is adjusted to the tinnitus frequency. Determining the tinnitus frequency is a difficult field anyway. So let's not continue the topic here, this is about Dr. Shore.
So I don't think Dr. Shore's device will be that expensive, why should it? It's a bit of electronic stuff, certainly with a long state-funded study phase beforehand. Auricle doesn't care. If Dr. Shore actually has tinnitus herself, she won't have the heart to overprice it.
I am (I know I repeat it from time to time) rather skeptical when it comes to bimodal stimulation methods. Well Dr. Shore's device could help a few, but with 99 participants, chance still plays too big a role for me. I don't think that will do much for the really hard-hit among us.
(I'm the one who predicted the Frequency Therapeutics crash, I just had to change my nickname as I got threats on another forum with the same nickname).
I am basing this on nothing but intuition but I feel very confident about this device, almost arrogant levels of confidence. My intuition has been spookily accurate in the past.That's nonsense. I've tested Lenire and I'm an absolute anti-Neuromod nerd. The acoustician looked at my audiogram and apparently made some adjustments to the software. Otherwise there are the same senseless sounds like piano, the sound of the sea, other instruments, etc. Complete nonsense, nothing is adjusted to the tinnitus frequency. Determining the tinnitus frequency is a difficult field anyway. So let's not continue the topic here, this is about Dr. Shore.
So I don't think Dr. Shore's device will be that expensive, why should it? It's a bit of electronic stuff, certainly with a long state-funded study phase beforehand. Auricle doesn't care. If Dr. Shore actually has tinnitus herself, she won't have the heart to overprice it.
I am (I know I repeat it from time to time) rather skeptical when it comes to bimodal stimulation methods. Well Dr. Shore's device could help a few, but with 99 participants, chance still plays too big a role for me. I don't think that will do much for the really hard-hit among us.
(I'm the one who predicted the Frequency Therapeutics crash, I just had to change my nickname as I got threats on another forum with the same nickname).
Your post above may disappoint a lot of hopefulls, but I think it's the healthy attitude to take.That's nonsense. I've tested Lenire and I'm an absolute anti-Neuromod nerd. The acoustician looked at my audiogram and apparently made some adjustments to the software. Otherwise there are the same senseless sounds like piano, the sound of the sea, other instruments, etc. Complete nonsense, nothing is adjusted to the tinnitus frequency. Determining the tinnitus frequency is a difficult field anyway. So let's not continue the topic here, this is about Dr. Shore.
So I don't think Dr. Shore's device will be that expensive, why should it? It's a bit of electronic stuff, certainly with a long state-funded study phase beforehand. Auricle doesn't care. If Dr. Shore actually has tinnitus herself, she won't have the heart to overprice it.
I am (I know I repeat it from time to time) rather skeptical when it comes to bimodal stimulation methods. Well Dr. Shore's device could help a few, but with 99 participants, chance still plays too big a role for me. I don't think that will do much for the really hard-hit among us.
(I'm the one who predicted the Frequency Therapeutics crash, I just had to change my nickname as I got threats on another forum with the same nickname).
Mine is also more intrusive on the left, and I've heard a lot of people say the same thing. Does this have any meaning or is it just a coincidence?the left ear is most problematic and intrusive.
Poll: Which Ear Is Your Tinnitus Worse In? | Tinnitus Talk Support ForumMine is also more intrusive on the left, and I've heard a lot of people say the same thing. Does this have any meaning or is it just a coincidence?
In a presentation I saw by Prof. Dirk De Ridder, statistics seems to indicate that a very small majority has tinnitus in the left ear than the right. He didn't say why but he did say that it's not uncommon for the tinnitus to pop up in the other ear as well after a couple of years. Fortunately for me, that has not happened yet.Mine is also more intrusive on the left, and I've heard a lot of people say the same thing. Does this have any meaning or is it just a coincidence?
This can be answered with a quick search on the forum. But basically Lenire is Bluetooth controlled preprogrammed crap with no precise timing tailored for different people and 0 placebo-controlled research.I'm trying to understand the difference between Lenire and Dr. Shore's device, being that both of them work via bimodal (electric/auditory) stimulation?
Is it just the details (e.g., current amplitude, timing between the electric and audio stimulus, etc)?
No, they are trying to do opposite things, both using bimodal stimulation. Lenire is trying to broadly stimulate everything in an attempt to lower the perceived noise in the narrow band that you actually experience tinnitus. Dr. Shore's device uses specific timings to calm and desynchronize the hyperactive fusiform cells, thus diminishing the actual tinnitus itself.I'm trying to understand the difference between Lenire and Dr. Shore's device, being that both of them work via bimodal (electric/auditory) stimulation?
Is it just the details (e.g., current amplitude, timing between the electric and audio stimulus, etc)?
Greetings to everyone who has requested updates on the tinnitus clinical trial at the University of Michigan.
Given the high volume of inquiries that we receive and our desire to provide a timely and consistent response, we are sending this message to all whom have contacted us.
Clinical trial update
We are pleased to report that our second trial is now complete. Like our first trial, this trial was a randomized, double blinded, sham controlled study (click here). Our results confirmed the results of the first trial and showed that extending the treatment period to six, instead of four weeks of treatment, resulted in greater TFI score improvement and sustained loudness reduction. Furthermore, the treatment effect showed improved treatment durability indicating long-lasting neural plasticity. We have submitted the findings for publication and will make the entire study available after the publication is accepted.
We are dedicated to bringing this novel therapy to the millions of global sufferers of this terrible affliction. As such, a private company was established (Auricle, Inc.), with the objective of obtaining regulatory clearance to commercialize the treatment. Note that we are not making any estimates or predictions currently concerning the timing and schedule of commercialization. The company is responsible for these efforts, and it is working diligently to make this a reality.
Please understand that we cannot provide any additional information at this time, so we will not be responding to additional queries for results.
Our very best wishes,
Susan E. Shore, PhD, and The Shore Lab